Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.71 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.